BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 21 filers reported holding BIOANALYTICAL SYS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $321,000 | +34.9% | 63,849 | -12.4% | 0.00% | 0.0% |
| Q1 2020 | $238,000 | -29.2% | 72,897 | +7.5% | 0.00% | -50.0% |
| Q4 2019 | $336,000 | +48.0% | 67,810 | +7.3% | 0.00% | +100.0% |
| Q3 2019 | $227,000 | +80.2% | 63,193 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $126,000 | -2.3% | 63,193 | +1.7% | 0.00% | 0.0% |
| Q1 2019 | $129,000 | +63.3% | 62,134 | 0.0% | 0.00% | – |
| Q4 2018 | $79,000 | -21.0% | 62,134 | 0.0% | 0.00% | – |
| Q3 2018 | $100,000 | -2.9% | 62,134 | 0.0% | 0.00% | – |
| Q2 2018 | $103,000 | +4.0% | 62,134 | 0.0% | 0.00% | – |
| Q1 2018 | $99,000 | -10.8% | 62,134 | +36.9% | 0.00% | – |
| Q4 2017 | $111,000 | +382.6% | 45,375 | +240.2% | 0.00% | – |
| Q3 2017 | $23,000 | +15.0% | 13,336 | +9.4% | 0.00% | – |
| Q2 2017 | $20,000 | +81.8% | 12,193 | +53.1% | 0.00% | – |
| Q1 2017 | $11,000 | +1000.0% | 7,963 | +430.9% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 1,500 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 1,500 | +35.1% | 0.00% | – |
| Q2 2016 | $1,000 | – | 1,110 | +176.1% | 0.00% | – |
| Q1 2016 | $0 | – | 402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 320,234 | $650,000 | 0.45% |
| Kessler Investment Group, LLC | 42,841 | $87,000 | 0.15% |
| NORTH STAR ASSET MANAGEMENT INC | 20,000 | $41,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 3 | $0 | 0.00% |
| UBS Group AG | 5,118 | $10,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 54,038 | $110,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 100 | $203,000 | 0.00% |
| STATE STREET CORP | 10,200 | $20,000 | 0.00% |
| MORGAN STANLEY | 14 | $0 | 0.00% |
| BANK OF MONTREAL /CAN/ | 230 | $0 | 0.00% |